RDC 40/2015 FAQ - Updated October 2025
Brazil Medical Device Notification Requirements. Expert guidance by Pure Global regulatory specialists
Official Document
Pure Global offers comprehensive notification support for Class I-II medical device manufacturers, streamlining documentation preparation, classification justification, labeling compliance, and ANVISA submission to achieve automatic approval within 30 days under RDC 40/2015.
Risk classification determination and justification per ANVISA rules
Technical reports, labeling, IFU translation and compliance verification
ANVISA portal submission and automatic approval tracking
Low and moderate-risk devices
Simplified vs. full registration
Automatic approval period
No explicit approval required
Frequently Asked Questions
General Notification Requirements
Class I & II Device Notification Process
Documentation Requirements
Labeling & IFU Requirements
Timeline & Approval Process
Note: This FAQ guide provides general information about regulatory requirements and should not be considered as legal advice. Regulations are subject to change. Always consult with qualified regulatory professionals for specific guidance.
Last updated: October 2025 | Based on RDC 40/2015 official documentation

